PF-05089771
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for PF-05089771, covering 2011-10-06 to 2019-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia [Phase 2]